Literature DB >> 20064696

Dual use of anabolic-androgenic steroids and narcotics in Sweden.

Nina Gårevik1, Anders Rane.   

Abstract

BACKGROUND: Anabolic-androgenic steroids (AAS) have long been used by body-builders seeking to increase muscle size, strength and beauty. AAS are sometimes used together with narcotic agents and are thought to serve as a gateway to narcotic substance use, but this theory has not yet been substantiated clinically or sociologically.
METHODS: Mandatory interviews were carried out with individuals (n=56) suspected of infringement of the narcotic laws in Sweden with confiscated and/or confirmed use of AAS. Data were collected over 12 months.
RESULTS: Seventy-three percent of subjects with confirmed use of AAS were also using narcotic substances. The use of AAS was preceded by the use of narcotic agents in 55% of subjects. Only one-fifth of the subjects in the study had used AAS before using narcotic agents.
CONCLUSION: Co-use of AAS and narcotics agents is frequent among young people taken into custody for criminal activity and investigated by the police in Sweden. The study does not lend support to the hypothesis that AAS are commonly a gateway drug to narcotic use. Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20064696     DOI: 10.1016/j.drugalcdep.2009.12.024

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  9 in total

1.  National Athletic Trainers' Association position statement: anabolic-androgenic steroids.

Authors:  Robert D Kersey; Diane L Elliot; Linn Goldberg; Gen Kanayama; James E Leone; Mike Pavlovich; Harrison G Pope
Journal:  J Athl Train       Date:  2012 Sep-Oct       Impact factor: 2.860

Review 2.  Illicit use of androgens and other hormones: recent advances.

Authors:  Gen Kanayama; Harrison G Pope
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-06       Impact factor: 3.243

Review 3.  Sex differences in opioid receptor mediated effects: Role of androgens.

Authors:  Jessica L Sharp; Tallia Pearson; Mark A Smith
Journal:  Neurosci Biobehav Rev       Date:  2022-01-04       Impact factor: 8.989

Review 4.  Polypharmacy among anabolic-androgenic steroid users: a descriptive metasynthesis.

Authors:  Dominic Sagoe; Jim McVeigh; Astrid Bjørnebekk; Marie-Stella Essilfie; Cecilie Schou Andreassen; Ståle Pallesen
Journal:  Subst Abuse Treat Prev Policy       Date:  2015-03-15

5.  Effects of different doses of testosterone on gonadotropins, 25-hydroxyvitamin D3, and blood lipids in healthy men.

Authors:  Nina Gårevik; Anders Rane; Linda Björkhem-Bergman; Lena Ekström
Journal:  Subst Abuse Rehabil       Date:  2014-12-10

6.  Effectiveness and implementation of a community-based prevention programme targeting anabolic androgenic steroid use in gyms: study protocol of a quasi-experimental control group study.

Authors:  Yasmina Molero; Johanna Gripenberg; Ann-Sofie Bakshi
Journal:  BMC Sports Sci Med Rehabil       Date:  2016-11-17

7.  Anabolic-androgenic steroid users receiving health-related information; health problems, motivations to quit and treatment desires.

Authors:  Ingrid Amalia Havnes; Marie Lindvik Jørstad; Christine Wisløff
Journal:  Subst Abuse Treat Prev Policy       Date:  2019-05-16

8.  The Anabolic Androgenic Steroid Treatment Gap: A National Study of Substance Use Disorder Treatment.

Authors:  Ingrid Amalia Havnes; Marie Lindvik Jørstad; Jim McVeigh; Marie-Claire Van Hout; Astrid Bjørnebekk
Journal:  Subst Abuse       Date:  2020-02-18

9.  Recruitment to doping and help-seeking behavior of eight female AAS users.

Authors:  Annica Börjesson; Nina Gårevik; Marja-Liisa Dahl; Anders Rane; Lena Ekström
Journal:  Subst Abuse Treat Prev Policy       Date:  2016-03-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.